{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,4,17]],"date-time":"2026-04-17T09:39:08Z","timestamp":1776418748730,"version":"3.51.2"},"reference-count":42,"publisher":"Impact Journals, LLC","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Aging"],"published-print":{"date-parts":[[2020,1,11]]},"DOI":"10.18632\/aging.102665","type":"journal-article","created":{"date-parts":[[2020,1,11]],"date-time":"2020-01-11T17:03:41Z","timestamp":1578762221000},"page":"912-930","source":"Crossref","is-referenced-by-count":35,"title":["Prognostic potential of PRPF3 in hepatocellular carcinoma"],"prefix":"10.18632","volume":"12","author":[{"given":"Yinlan","family":"Liu","sequence":"first","affiliation":[{"name":"Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yuhan","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Yan","family":"Luo","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Juan","family":"Wang","sequence":"additional","affiliation":[{"name":"Department of Clinical Laboratory, Tongde Hospital of Zhejiang Province, Hangzhou, Zhejiang 310012, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Xiangyun","family":"Lu","sequence":"additional","affiliation":[{"name":"State Key Laboratory for Diagnosis and Treatment of Infectious Diseases, National Clinical Research Center for Infectious Diseases, The First Affiliated Hospital, College of Medicine, Zhejiang University, Hangzhou, Zhejiang 310003, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Zongxing","family":"Yang","sequence":"additional","affiliation":[{"name":"The Second Department of Infectious Disease, Xixi Hospital of Hangzhou, The Affiliated Hospital of Zhejiang Chinese Medical University, Hangzhou, Zhejiang 310023, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin","family":"Yang","sequence":"additional","affiliation":[{"name":"Department of Translational Medicine Center, Affiliated Hospital of Hangzhou Normal University, Hangzhou Normal University, Hangzhou, Zhejiang 310015, P.R. China"}],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"7892","published-online":{"date-parts":[[2020,1,11]]},"reference":[{"key":"1","doi-asserted-by":"publisher","first-page":"E359","DOI":"10.1002\/ijc.29210","article-title":"Cancer incidence and mortality worldwide: sources, methods and major patterns in GLOBOCAN 2012.","volume":"13","author":"Bray","year":"2015","journal-title":"Int J Cancer"},{"key":"2","doi-asserted-by":"publisher","first-page":"1767","DOI":"10.1002\/hep.27222","article-title":"Epidemiology of hepatocellular carcinoma in the United States: where are we? Where do we go?","volume":"6","author":"Kanwal","year":"2014","journal-title":"Hepatology"},{"key":"3","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1186\/s12935-018-0538-7","article-title":"Resistance a major hindrance to chemotherapy in hepatocellular carcinoma: an insight.","volume":"1","author":"Mukherjee","year":"2018","journal-title":"Cancer Cell Int"},{"key":"4","doi-asserted-by":"publisher","first-page":"E486","DOI":"10.3390\/cancers11040486","article-title":"Diagnostic and Prognostic Potential of AKR1B10 in Human Hepatocellular Carcinoma.","volume":"1","author":"Davis","year":"2019","journal-title":"Cancers (Basel)"},{"key":"5","doi-asserted-by":"publisher","first-page":"1181","DOI":"10.1038\/s41418-018-0231-3","article-title":"Function, clinical application, and strategies of Pre-mRNA splicing in cancer.","volume":"2","author":"Hoheisel","year":"2019","journal-title":"Cell Death Differ"},{"key":"6","doi-asserted-by":"publisher","first-page":"e1527","DOI":"10.1002\/wrna.1527","article-title":"Splicing and cancer: challenges and opportunities.","volume":"1","author":"da Silva","year":"2019","journal-title":"Wiley Interdiscip Rev RNA"},{"key":"7","doi-asserted-by":"publisher","first-page":"689","DOI":"10.1080\/15476286.2018.1457936","article-title":"When SUMO met splicing.","volume":"1","author":"Srebrow","year":"2018","journal-title":"RNA Biol"},{"key":"8","doi-asserted-by":"publisher","first-page":"6729","DOI":"10.1093\/nar\/gkx213","article-title":"SUMO conjugation to spliceosomal proteins is required for efficient pre-mRNA splicing.","volume":"4","author":"Srebrow","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"9","doi-asserted-by":"publisher","first-page":"8743","DOI":"10.18632\/oncotarget.7087","article-title":"An individualized prognostic signature for gastric cancer patients treated with 5-Fluorouracil-based chemotherapy and distinct multi-omics characteristics of prognostic groups.","volume":"7","author":"Guo","year":"2016","journal-title":"Oncotarget"},{"key":"10","doi-asserted-by":"publisher","first-page":"1191","DOI":"10.1053\/j.gastro.2008.01.027","article-title":"EPS15R, TASP1, and PRPF3 are novel disease candidate genes targeted by HNF4alpha splice variants in hepatocellular carcinomas.","volume":"13","author":"Borlak","year":"2008","journal-title":"Gastroenterology"},{"key":"11","doi-asserted-by":"publisher","first-page":"830","DOI":"10.1172\/JCI87583","article-title":"Dosage-dependent copy number gains in E2f1 and E2f3 drive hepatocellular carcinoma.","volume":"12","author":"Perez","year":"2017","journal-title":"J Clin Invest"},{"key":"12","doi-asserted-by":"publisher","first-page":"D522","DOI":"10.1093\/nar\/gkx981","article-title":"The DifferentialNet database of differential protein-protein interactions in human tissues.","volume":"4","author":"Yeger-Lotem","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"13","doi-asserted-by":"publisher","first-page":"3144","DOI":"10.18632\/oncotarget.13673","article-title":"Down-regulation of salt-inducible kinase 1 (SIK1) is mediated by RNF2 in hepatocarcinogenesis.","volume":"8","author":"Qu","year":"2017","journal-title":"Oncotarget"},{"key":"14","doi-asserted-by":"publisher","first-page":"17006","DOI":"10.1038\/srep17006","article-title":"CUL4A facilitates hepatocarcinogenesis by promoting cell cycle progression and epithelial-mesenchymal transition.","volume":"5","author":"Liang","year":"2015","journal-title":"Sci Rep"},{"key":"15","doi-asserted-by":"publisher","DOI":"10.1093\/database\/bav095","article-title":"RegNetwork: an integrated database of transcriptional and post-transcriptional regulatory networks in human and mouse.","volume":"201","author":"Wu","year":"2015","journal-title":"Database (Oxford)"},{"key":"16","doi-asserted-by":"publisher","first-page":"E1888","DOI":"10.3390\/ijms20081888","article-title":"Transcriptional Regulation Factors of the Human Mitochondrial Aspartate\/Glutamate Carrier Gene, Isoform 2 (): USF1 as Basal Factor and FOXA2 as Activator in Liver Cells.","volume":"2","author":"Infantino","year":"2019","journal-title":"Int J Mol Sci"},{"key":"17","first-page":"1665","article-title":"POU2F1 promotes growth and metastasis of hepatocellular carcinoma through the FAT1 signaling pathway.","volume":"7","author":"Hu","year":"2017","journal-title":"Am J Cancer Res"},{"key":"18","doi-asserted-by":"publisher","first-page":"e103304","DOI":"10.1371\/journal.pone.0103304","article-title":"Silencing of hypoxia-inducible factor-1\u03b2 induces anti-tumor effects in hepatoma cell lines under tumor hypoxia.","volume":"9","author":"Han","year":"2014","journal-title":"PLoS One"},{"key":"19","doi-asserted-by":"publisher","first-page":"204","DOI":"10.1038\/cr.2013.158","article-title":"Amplification of MPZL1\/PZR promotes tumor cell migration through Src-mediated phosphorylation of cortactin in hepatocellular carcinoma.","volume":"2","author":"He","year":"2014","journal-title":"Cell Res"},{"key":"20","doi-asserted-by":"publisher","first-page":"662","DOI":"10.1002\/ijc.32134","article-title":"NUF2 is a valuable prognostic biomarker to predict early recurrence of hepatocellular carcinoma after surgical resection.","volume":"14","author":"Hui","year":"2019","journal-title":"Int J Cancer"},{"key":"21","doi-asserted-by":"publisher","first-page":"20105","DOI":"10.1074\/jbc.M115.655340","article-title":"Lysosomal-associated Transmembrane Protein 4B (LAPTM4B) Decreases Transforming Growth Factor \u03b21 (TGF-\u03b21) Production in Human Regulatory T Cells.","volume":"29","author":"Lucas","year":"2015","journal-title":"J Biol Chem"},{"key":"22","doi-asserted-by":"publisher","first-page":"871","DOI":"10.1053\/j.gastro.2008.06.032","article-title":"Myeloid-derived suppressor cells in inflammatory bowel disease: a new immunoregulatory pathway.","volume":"13","author":"Greten","year":"2008","journal-title":"Gastroenterology"},{"key":"23","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1111\/hepr.12831","article-title":"Circulating CD14HLA-DRmyeloid-derived suppressor cells predicted early recurrence of hepatocellular carcinoma after surgery.","volume":"4","author":"Yang","year":"2017","journal-title":"Hepatol Res"},{"key":"24","doi-asserted-by":"publisher","first-page":"2963","DOI":"10.1158\/1078-0432.CCR-18-2445","article-title":"Alternative RNA Splicing as a Potential Major Source of Untapped Molecular Targets in Precision Oncology and Cancer Disparities.","volume":"2","author":"Patierno","year":"2019","journal-title":"Clin Cancer Res"},{"key":"25","doi-asserted-by":"publisher","first-page":"2025","DOI":"10.2174\/092986711795590110","article-title":"Cyclin dependent kinase 1 inhibitors: a review of recent progress.","volume":"1","author":"Fang","year":"2011","journal-title":"Curr Med Chem"},{"key":"26","doi-asserted-by":"publisher","first-page":"57","DOI":"10.1016\/j.ccell.2017.05.009","article-title":"Common Molecular Subtypes Among Asian Hepatocellular Carcinoma and Cholangiocarcinoma.","volume":"3","author":"Auewarakul","year":"2017","journal-title":"Cancer Cell"},{"key":"27","doi-asserted-by":"publisher","first-page":"125","DOI":"10.1007\/s12072-018-9919-1","article-title":"Goals and targets for personalized therapy for HCC.","volume":"1","author":"Pillai","year":"2019","journal-title":"Hepatol Int"},{"key":"28","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1101\/gad.319590.118","article-title":"The splicing factor U2AF1 contributes to cancer progression through a noncanonical role in translation regulation.","volume":"3","author":"Larson","year":"2019","journal-title":"Genes Dev"},{"key":"29","doi-asserted-by":"publisher","first-page":"8971","DOI":"10.1038\/ncomms9971","article-title":"Systematic pan-cancer analysis of tumour purity.","volume":"6","author":"Butte","year":"2015","journal-title":"Nat Commun"},{"key":"30","doi-asserted-by":"publisher","first-page":"269","DOI":"10.1016\/j.gpb.2018.07.003","article-title":"HCCDB: A Database of Hepatocellular Carcinoma Expression Atlas.","volume":"1","author":"Gu","year":"2018","journal-title":"Genomics Proteomics Bioinformatics"},{"key":"31","doi-asserted-by":"publisher","first-page":"649","DOI":"10.1016\/j.neo.2017.05.002","article-title":"UALCAN: A Portal for Facilitating Tumor Subgroup Gene Expression and Survival Analyses.","volume":"1","author":"Varambally","year":"2017","journal-title":"Neoplasia"},{"key":"32","doi-asserted-by":"publisher","first-page":"W98","DOI":"10.1093\/nar\/gkx247","article-title":"GEPIA: a web server for cancer and normal gene expression profiling and interactive analyses.","volume":"4","author":"Zhang","year":"2017","journal-title":"Nucleic Acids Res"},{"key":"33","doi-asserted-by":"publisher","first-page":"pl1","DOI":"10.1126\/scisignal.2004088","article-title":"Integrative analysis of complex cancer genomics and clinical profiles using the cBioPortal.","volume":"6","author":"Schultz","year":"2013","journal-title":"Sci Signal"},{"key":"34","doi-asserted-by":"publisher","first-page":"D956","DOI":"10.1093\/nar\/gkx1090","article-title":"LinkedOmics: analyzing multi-omics data within and across 32 cancer types.","volume":"4","author":"Zhang","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"35","doi-asserted-by":"publisher","first-page":"W234","DOI":"10.1093\/nar\/gkz240","article-title":"NetworkAnalyst 3.0: a visual analytics platform for comprehensive gene expression profiling and meta-analysis.","volume":"4","author":"Xia","year":"2019","journal-title":"Nucleic Acids Res"},{"key":"36","doi-asserted-by":"publisher","first-page":"482","DOI":"10.1038\/s41596-018-0103-9","article-title":"Pathway enrichment analysis and visualization of omics data using g:Profiler, GSEA, Cytoscape and EnrichmentMap.","volume":"1","author":"Bader","year":"2019","journal-title":"Nat Protoc"},{"key":"37","doi-asserted-by":"publisher","first-page":"e108","DOI":"10.1158\/0008-5472.CAN-17-0307","article-title":"TIMER: A Web Server for Comprehensive Analysis of Tumor-Infiltrating Immune Cells.","volume":"7","author":"Liu","year":"2017","journal-title":"Cancer Res"},{"key":"38","doi-asserted-by":"publisher","first-page":"174","DOI":"10.1186\/s13059-016-1028-7","article-title":"Comprehensive analyses of tumor immunity: implications for cancer immunotherapy.","volume":"1","author":"Liu","year":"2016","journal-title":"Genome Biol"},{"key":"39","doi-asserted-by":"publisher","first-page":"2612","DOI":"10.1038\/ncomms3612","article-title":"Inferring tumour purity and stromal and immune cell admixture from expression data.","volume":"4","author":"Stemke-Hale","year":"2013","journal-title":"Nat Commun"},{"key":"40","doi-asserted-by":"publisher","first-page":"1965","DOI":"10.1016\/j.celrep.2019.01.080","article-title":"Immune Cell Types and Secreted Factors Contributing to Inflammation-to-Cancer Transition and Immune Therapy Response.","volume":"2","author":"Han","year":"2019","journal-title":"Cell Rep"},{"key":"41","doi-asserted-by":"publisher","first-page":"4200","DOI":"10.1093\/bioinformatics\/btz210","article-title":"TISIDB: an integrated repository portal for tumor-immune system interactions.","volume":"3","author":"Zhang","year":"2019","journal-title":"Bioinformatics"},{"key":"42","doi-asserted-by":"publisher","first-page":"665","DOI":"10.5351\/CSAM.2015.22.6.665","article-title":"ppcor: An R Package for a Fast Calculation to Semi-partial Correlation Coefficients.","volume":"2","author":"Kim","year":"2015","journal-title":"Commun Stat Appl Methods"}],"container-title":["Aging"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102665","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,9,2]],"date-time":"2020-09-02T19:46:48Z","timestamp":1599076008000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.aging-us.com\/lookup\/doi\/10.18632\/aging.102665"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2020,1,11]]},"references-count":42,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2020,1,15]]}},"alternative-id":["102665","31926109"],"URL":"https:\/\/doi.org\/10.18632\/aging.102665","relation":{},"ISSN":["1945-4589"],"issn-type":[{"value":"1945-4589","type":"electronic"}],"subject":[],"published":{"date-parts":[[2020,1,11]]}}}